GGrantIndex
← Search

CORE--Protocol Review Monitoring System

$23,087P30FY2006CANIH

University Of Nebraska Medical Center, Omaha NE

Investigators

Linked publications, trials & patents

Paper 39684445Paper 39678719Paper 39605468Paper 39580490Paper 39573886Paper 39456534Paper 39450301Paper 39436320Paper 39420209Paper 39386613Paper 39386448Paper 39384153Paper 39339419Paper 39224072Paper 39219576Paper 39151112Paper 39141488Paper 39130636Paper 39125017Paper 39110778Paper 39107463Paper 39080401Paper 39013847Paper 38974465Paper 38969056Paper 38946943Paper 38900505Paper 38853862Paper 38847506Paper 38775157Paper 38770637Paper 38733583Paper 38712184Paper 38704607Paper 38687198Paper 38683788Paper 38672426Paper 38617282Paper 38603627Paper 38547055Paper 38542184Paper 38514303Paper 38482976Paper 38445903Paper 38437585Paper 38429478Trial NCT03226418Trial NCT03073785Trial NCT02874404Trial NCT02833701Trial NCT02654119Trial NCT02561273Trial NCT02553447Trial NCT02168270Trial NCT01959672Trial NCT01825603Trial NCT01750073Trial NCT01555632Trial NCT01431209Trial NCT01336933Trial NCT01336920Trial NCT01307956Trial NCT01106898Trial NCT01093183Trial NCT01068327Trial NCT01044745Trial NCT01035463Trial NCT00959244Trial NCT00856037Trial NCT00816413Trial NCT00736450Trial NCT00679029Trial NCT00666731Trial NCT00665457Trial NCT00625690Trial NCT00617799Trial NCT00611351Trial NCT00607828Trial NCT00602797Trial NCT00577798Trial NCT00569543Trial NCT00503880Trial NCT00499083Trial NCT00496756Trial NCT00486356Trial NCT00483561Trial NCT00483366Trial NCT00482807Trial NCT00089024Trial NCT00082641Trial NCT00007865Trial NCT00007852Trial NCT00006478Trial NCT00004874Trial NCT00004198Trial NCT00004197Trial NCT00004192Trial NCT00004112Patent 7166704Patent 6680196

Abstract

DESCRIPTION (adapted from the application): All cancer-related protocols involving a UNMC faculty member or a UNMC Eppley Cancer Center member require review by the Scientific Review Committee. The mission of the Scientific Review Committee is complementary to that of the institutional Review Board (IRB). It does not duplicate or overlap the responsibilities of the IRB, which focuses on the protection of human subjects. The IRB will not issue a full approval for any cancerrelated study involving human subjects without first receiving notice of full approval from the Scientific Review Committee which attests that all scientific requirements for the study have been met. The Scientific Review Committee focuses on the scientific merit, prioritization, and progress of the research. The specific objective of the Scientific Review Committee include: ? Review scientific merit of cancer-related research involving human subjects at the UNMC Eppley Cancer Center. ? Foster development of innovative, collaborative, and scientifically sound studies which focus on the prevention, detection, diagnosis, and treatment of cancer including long-term follow-up and supportive care. ? Aid investigators in the establishment of the prioritization of studies and assure optimal allocation of the Cancer Center clinical and community resources. ? Assist investigators in the development and conduct of clinical cancer studies in conjunction with the Clinical Trials Office. ? Monitor progress of protocols relative to study objectives. ? Monitor accrual, data collection, and safety in conjunction with the Data Safety and Monitoring Committee and the Audit Committee. ? Provide a standard protocol format for submission and review.

View original record on NIH RePORTER →